2520
M. A. Guerrero, L. D. Miranda / Tetrahedron Letters 47 (2006) 2517–2520
Angew. Chem., Int. Ed. 2004, 43, 95; (l) Bennasar, M.-Ll.;
Roca, T.; Ferrando, F. Tetrahedron Lett. 2004, 45, 5605;
(d, J = 4.2 Hz, 1H), 6.19 (d, J = 4.2 Hz, 1H), 4.13 (q,
J = 7.2 Hz, 2H), 3.98 (q, J = 13.5 Hz, 1H), 3.93 (s, 3H),
1.51 (d, J = 13.5 Hz, 3H), 1.19 (t, J = 7.2 Hz, 3H); 13C
NMR (75 MHz, CD3COCD3) d ppm: 179.8, 172.8, 143.3,
133.2, 124.5, 108.7, 61.6, 37.5, 32.6, 16.7, 14.3. IR (neat,
cmÀ1) m 1734, 1661, 1468; EM (EI) m/z = M+ (%).
´
Menes-Arzate, M.; Martınez, R.; Cruz-Almanza, R.; Osor-
nio, Y. M.; Muchowski, J. M.; Miranda, L. D. J. Org.
Chem. 2004, 69, 4001.
´
5. Osornio, Y. M.; Cruz-Almanza, R.; Jimenez-Montano, V.;
˜
1
Miranda, L. D. Chem. Commun. 2003, 2316–2317.
6. For examples of the use of Fe(II) in similar processes: (a)
Muchowski, J. M.; Cho, I. S.; Jaime-Figueroa, S.; Artis, R.
D. J. Org. Chem. 1994, 59, 2456; (b) Miranda, L. D.; Cruz-
Almanza, R.; Pavon, M. ARKIVOC 2002, 15–22.
Compound 19: H NMR (200 MHz, CD3COCD3) d ppm:
11.4 (br s, 1H), 7.36–7.34 (m, 1H), 6.39–6.37 (m, 1H), 4.54–
4.36 (m, 2H), 4.23 (dd, J = 11.5, 8.8 Hz, 1H), 2.89–2.78 (m,
1H) 2.68–2.56 (m, 1H); 13C NMR (75 MHz, CD3COCD3) d
ppm: 175.8, 172.9, 139.5, 123.3, 120.3, 96.19, 122.4, 110.9,
67.5, 39.7; IR (neat, cmÀ1) m 3409, 1770, 1668, 1167; EM
(IE), m/z = (M+) 295 (5%), (M++1) 296, 178 (100%).
7. Typical experimental procedure: A solution of Et3B (1.0 M
in THF) was added dropwise (2 equiv/14 h) to a stirred
solution of the xanthate (1 equiv), the aromatic compound
(3 equiv) and FeSO4 (1 equiv) in CH2Cl2/EtOH/H2O (6:3:1,
4 ml/mmol of the xanthate). The organic solvent was
removed under reduced pressure and the crude residue
extracted with EtOAc. The organic layer was dried with
Na2SO4, and solvent removed under reduced pressure. The
product was purified by chromatography on a silica gel
column (ethyl acetate/hexane 8:2) to furnish the desired
product. Selected spectral data. Compound 14: 1H NMR
(200 MHz, CD3COCD3) d ppm: 7.87–7.85 (m, 2H), 7.61–
7.47 (m, 3H), 6.81 (dd, J = 3.9, 2.7 Hz, 1H), 6.28 (dd,
J = 3.9, 2.7 Hz, 1H), 4.56–4.33 (m, 2H), 4.20 (dd, J = 11.0,
9.0 MHz, 1H), 2.9–2.55 (m, 2H). 13C NMR (75 MHz,
CD3COCD3) d ppm: 184.3, 176.2, 139.7, 136.5, 132.4,
132.0, 129.5, 129.1, 119.9, 109.8, 67.5, 39.6, 30.4; IR (neat,
cmÀ1) m 3273, 1767, 1612; MS (EI) (m/z), M+ 255 (90%), 77
(100%). Compound 15: 1H NMR (300 MHz, CDCl3) d
ppm: 10.41 (br s, 1H), 7.89 (dd, J = 8.5, 1.8 Hz, 2H), 7.57–
7.43 (m, 3H), 6.81 (dd, J = 3.8, 2.5 Hz, 1H), 6.18
(dd, J = 3.8, 2.5 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.77
(s, 3H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR (300 MHz,
CDCl3) d ppm: 184.2, 169.4, 138.6, 131.9, 131.6, 131.2,
128.9, 128.2, 119.8, 110.6, 61.4, 33.6, 14.1; IR (neat, cmÀ1) m
3286, 2922, 1737, 1606; HRMS FAB+ (M+1, m/z) calcd for
C15H16O3N: 258.1130, found: 258.1130. Compound 16.
1
Compound 20: H NMR (300 MHz, CD3COCD3) d ppm:
11.05 (br s, 1H), 9.46 (s, 1H), 6.93 (dd, J = 3.81, 2.34 Hz,
1H), 6.27 (dd, J = 3.81, 2.34 Hz, 1H), 4.50–4.33 (m, 2H),
4.13 (dd, J = 11.13, 9.09 Hz, 1H), 2.65–2.52 (m, 2H); 13C
NMR (75 MHz, CD3COCD3) d ppm: 179.1, 176.0, 137.2,
134.3, 121.3, 110.0, 67.4, 39.7, 30.3; IR (neat, cmÀ1) m 3259,
1767, 1647; EM (EI), m/z (M+): 179 (100%). Compound 21:
1H NMR (300 MHz, CD3COCD3) d ppm: 10.75 (br s, 1H),
9.43 (s, 1H), 6.88 (dd, 1 = 3.81, 2.34 Hz, 1H), 6.17 (dd,
J = 3.8, 2.34 Hz, 1H), 5.20 (q, J = 7.02 Hz, 1H) 4.52–4.40
(m, 2H), 4.11–3.96 (m, 2H), 1.51 (d, J = 7.02 Hz, 3H); 13C
NMR (75 MHz, CD3COCD3) d 178.9, 173.3, 154.5, 14.6,
133.8, 121.1, 109.6, 63.2, 43.8, 37.5, 17.8; IR (neat, cmÀ1) m
3297, 1776, 1698, 1649; EM (EI), m/z (M+): 236 (15%), 149
1
(100%). Compound 22: H NMR (300 MHz, CD3COCD3)
d ppm: 11.75 (br, 1H), 8.07–8.02 (m, 1H), 7.48–7.42 (m,
1H), 7.25–7.13 (m, 2H), 4.92 (dd, J = 12.0, 9.3 Hz, 1H),
4.58 (td, J = 8.6, 2.3 Hz, 1H), 4.45 (ddd, J = 11.3, 9.8,
6.8 Hz, 1H), 3.87 (s, 3H), 2.79–2.61 (m, 2H). 13C NMR
(300 MHz, CD3COCD3) d ppm: 176.0, 166.5, 143.8, 136.6,
127.83, 123.5, 122.3, 122.2, 112.4, 105.6, 67.4, 51.0, 40.3,
30.8; IR (neat, cmÀ1) m 3452, 2925, 1736, 1624; EM (EI),
m/z (M+): 259 (30%), 227 (100%). Compound 23: 1H NMR
(300 MHz, CD3COCD3) d ppm: 10.95 (br s 1H) 8.07–8.00
(m, 1H), 7.50–7.45 (m, 1H), 7.18–7.12 (m, 2H), 6.13 (q,
J = 7.0 Hz, 1H), 4.49 (t, J = 7.9 Hz, 2H), 4.08–4.032 (m,
2H), 3.8 (s, 3H), 1.64 (t, J = 7.0 Hz, 3H); 13C NMR
(75 MHz, CD3COCD3) d ppm: 174.3, 166.2, 154.0, 146.0,
136.4, 127.7, 123.0, 122.1, 121.9, 112.5, 104.5, 63.1, 50.8,
43.7, 37.5, 17.2; IR (neat, cmÀ1) m 3338, 2951, 1779, 1693;
EM (EI), m/z (M+): 316 (10%), 71 (100%). Compound 24:
1H NMR (200 MHz, CD3COCD3) d ppm: 10.08 (br s, 1H),
7.47 (d, J = 7.5Hz, 1H), 7.37 (d, J = 7.5 Hz, 1H), 7.10–6.91
(m, 2H), 6.33 (dd, J = 2.0, 1.0 Hz, 1H), 4.14 (q, J = 7 Hz,
2H), 3.84 (d, J = 1 Hz, 2H), 1.22 (t, J = 7 Hz, 3H); 13C
NMR (75 MHz, CD3COCD3) d ppm: 170.6, 137.7, 132.6,
129.5, 121.8, 120.5, 119.9, 111.7, 101.9, 61.3, 34.6, 14.4; IR
1
White solid mp 72–74 °C. H NMR (300 MHz, CDCl3) d
ppm: 10.12 (br s, 1H, NH), 7.86–7.89 (m, 2H), 7.44–7.57
(m, 3H), 6.80 (dd, J = 3.6 Hz, 2.4 Hz, 1H), 6.18 (dd,
J = 3.6 Hz, 2.4 Hz, 1H), 3.91 (q, J = 7.2 Hz, 1H), 3.71 (s,
3H), 1.59 (d, J = 7.2 Hz, 3H); HRMS FAB+ (M+1, m/z)
calcd for C15H16O3N1: 258.1130, found: 258.1125. Com-
1
pound 17. H NMR (300 MHz, CD3COCD3) d ppm: 9.51
(s, 1H), 6.94 (d, J = 4.2 Hz, 1H), 6.25 (dd, J = 3.9, 0.4 Hz,
1H), 4.55–4.37 (m, 2H), 4.27 (dd, J = 10.8, 9.0 Hz, 1H),
4.00 (s, 3H), 2.81–2.73 (m, 1H), 2.66–2.52 (m, 1H); 13C
NMR (75 MHz, CD3COCD3) d ppm: 179.83, 175.6, 139.9,
133.7, 124.3, 108.9, 67.5, 38.1, 32.9, 29.6; IR (neat, cmÀ1) m
1768, 1659; EM (EI) m/z = M+ 193 (100%). Compound 18:
1H NMR (300 MHz, CD3COCD3) d ppm: 9.49 (s, 1H), 6.92
(neat, cmÀ1
C12H13NO2 = 204.1025, found 204.1017.
) m 3397, 2926, 1728; HMRS calcd for